Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Martin

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Pediatric Dermatology|March 1, 1994
Management of a young patient with xeroderma pigmentosumS Leal-Khouri, G J Hruza, L L Hruza, et al.
International Journal for Parasitology|May 1, 1997
Analysis of immunological cross-protection and sensitivities to anticoccidial drugs among five geographical and temporal strains of Eimeria maximaA G Martin, H D Danforth, J R Barta, et al.
The British Journal of Dermatology|June 1, 1992
Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acneA G Martin, C C Weaver, C J Cockerell, et al.
Wisconsin Medical Journal|November 1, 1973
Cystadenoma of the liver; a rare tumor. Description of a case; review of the literatureA G Martin, W P Wendt, D J LaFond, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 27, 2010
[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience]O Zebentout, R Apardian, L Beaulieu, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Allopregnanolone levels and symptom improvement in severe premenstrual syndromeEllen W Freeman, Cheryl A Frye, Karl Rickels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial resultsM Duvic, K Hymes, P Heald, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2023
Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapyT Reynaud, I Ben Aicha, D Carignan, et al.
Archives of Dermatology|May 18, 2001
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphomaM Duvic, A G Martin, Y Kim, et al.
Brachytherapy|December 16, 2025
A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapyF Lacroix, E Poulin, C Bélanger, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Pediatric Dermatology|March 1, 1994
Management of a young patient with xeroderma pigmentosumS Leal-Khouri, G J Hruza, L L Hruza, et al.
International Journal for Parasitology|May 1, 1997
Analysis of immunological cross-protection and sensitivities to anticoccidial drugs among five geographical and temporal strains of Eimeria maximaA G Martin, H D Danforth, J R Barta, et al.
The British Journal of Dermatology|June 1, 1992
Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acneA G Martin, C C Weaver, C J Cockerell, et al.
Wisconsin Medical Journal|November 1, 1973
Cystadenoma of the liver; a rare tumor. Description of a case; review of the literatureA G Martin, W P Wendt, D J LaFond, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 27, 2010
[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience]O Zebentout, R Apardian, L Beaulieu, et al.
Journal of Clinical Psychopharmacology|September 28, 2002
Allopregnanolone levels and symptom improvement in severe premenstrual syndromeEllen W Freeman, Cheryl A Frye, Karl Rickels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial resultsM Duvic, K Hymes, P Heald, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2023
Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapyT Reynaud, I Ben Aicha, D Carignan, et al.
Archives of Dermatology|May 18, 2001
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphomaM Duvic, A G Martin, Y Kim, et al.
Brachytherapy|December 16, 2025
A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapyF Lacroix, E Poulin, C Bélanger, et al.
Pageof 5